Men at fourfold higher risk for esophageal adenocarcinoma
Men, particularly those with adenocarcinoma, have a significantly higher risk for developing esophageal cancer compared with women worldwide, with a fourfold greater risk globally and an eightfold greater risk in North America, according to new global ...
Healio - Fri, 17 Oct 2014 11:33

UK tops global league table for gullet cancer -- adenocarcinoma -- in men
Rates of SCC have remained fairly stable or have even fallen over the past few years, but those of adenocarcinoma have risen, particularly in high income countries. In 2012, oesophageal cancer was the eighth most common cancer worldwide.
EurekAlert (press release) - Wed, 15 Oct 2014 15:30

UK men have highest risk of oesophageal cancer in the world
OnMedica - Thu, 16 Oct 2014 03:07

UK tops WHO gullet cancer table and obesity may be factor
BBC News - Wed, 15 Oct 2014 17:13

The UK Has Highest Gullet Cancer Rate In The World - And Obesity May Be To ...
Huffington Post UK - Thu, 16 Oct 2014 03:52

Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma ...
The data show that patients in the predefined adenocarcinoma subgroup treated with the vintafolide plus docetaxel combination had a 27 percent reduction in risk of the disease worsening or death (HR=0.73, p=0.0899, one-sided test), and a 30 percent ...
MarketWatch - Sat, 27 Sep 2014 07:15

Should Endocyte abandon a cancer drug that works?
Indianapolis Business Journal - Mon, 29 Sep 2014 11:52

Vintafolide Added to Docetaxel Improves Survival in Folate Receptor-Positive ...
OncLive - Sun, 28 Sep 2014 09:30

Endocytes TARGET Interim Data Positive for Lung Cancer - Mon, 29 Sep 2014 13:31

Inflammatory biomarkers may signal higher risk of esophageal adenocarcinoma
Identifying individuals at increased risk of progressing from Barrett's esophagus to esophageal adenocarcinoma could greatly improve outcomes through earlier detection. Inflammatory biomarkers have been used to help predict onset of other cancers, but ...
Fred Hutchinson Cancer Research Center News - Mon, 20 Oct 2014 14:11

Platinum-based chemotherapy extended OS in BRCA-associated pancreatic ...
Patients with advanced BRCA-associated pancreatic ductal adenocarcinoma treated with platinum-based chemotherapy experienced longer OS than those who received non-platinum therapy, according to study results.
Healio - Tue, 07 Oct 2014 01:15

XAGE1 antibody confers survival benefits to lung adenocarcinoma patients
Patients with advanced lung adenocarcinoma who produce the XAGE1 (GAGED2a) antibody appear to survive twice as long as those who do not produce it, Japanese study data show. Eiichi Nakayama (Kawasaki University of Medical Welfare, Okayama) ... - Wed, 24 Sep 2014 14:11

Nintedanib* receives positive CHMP opinion for second-line treatment of ...
Adenocarcinoma is the most common type of lung cancer and accounts for nearly half of all NSCLC cases. The majority of patients with advanced adenocarcinoma will experience disease progression after first-line chemotherapy and there is still a ...
Business Wire (press release) - Fri, 26 Sep 2014 04:26

PET Screening for Metastatic Colorectal Adenocarcinoma—Reply
In Reply Drs Wong and Jolepalem and Dr Hofman and colleagues question the value of PET after preoperative chemotherapy. In our trial, a baseline CT was used to decide if the patient was a candidate for hepatic surgery. Most patients (70%) had received ...
JAMA: The Journal of the American Medical Association - Tue, 23 Sep 2014 13:03

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014